These changes in cancer metabolism are controlled by carcinogenic mutations (e.g., MYC, phosphatase and tensin homologue; PTEN, AKT serine/threonine kinase, and phosphoinositide 3-kinase; PI3K). This evidence concerns the gene AKT1 and cancer.